Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT03251417 · TERMINATED
Trial details
- NCT number
- NCT03251417
- Sponsor
- Peking University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-10
- Primary completion
- 2021-04-25
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.